Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy.
Sterling M, Al-Ismaili Z, McMahon KR, Piccioni M, Pizzi M, Mottes T, Lands LC, Abish S, Fleming AJ, Bennett MR, Palijan A, Devarajan P, Goldstein SL, O'Brien MM, Zappitelli M. Sterling M, et al. Pediatr Blood Cancer. 2017 Oct;64(10):10.1002/pbc.26538. doi: 10.1002/pbc.26538. Epub 2017 Apr 18. Pediatr Blood Cancer. 2017. PMID: 28417544 Free PMC article. Clinical Trial.
Viral surveillance using PCR during treatment of AML and ALL.
Dixon SB, Lane A, O'Brien MM, Burns KC, Mangino JL, Breese EH, Absalon MJ, Perentesis JP, Phillips CL. Dixon SB, et al. Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26752. Epub 2017 Aug 9. Pediatr Blood Cancer. 2018. PMID: 28792686
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective.
Rubinstein JD, Shah R, Breese EH, Burns KC, Mangino JL, Norris RE, Lee L, Mizukawa B, O'Brien MM, Phillips CL, Perentesis JP, Pommert L, Absalon MJ. Rubinstein JD, et al. Pediatr Blood Cancer. 2021 Aug;68(8):e29126. doi: 10.1002/pbc.29126. Epub 2021 May 21. Pediatr Blood Cancer. 2021. PMID: 34019326
The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL.
Rubinstein JD, Breese EH, Krupski MC, O'Brien MM, Dandoy CE, Mizukawa B, Khoury R, Norris RE, Davies SM, Phillips CL. Rubinstein JD, et al. Transplant Cell Ther. 2023 May;29(5):311.e1-311.e7. doi: 10.1016/j.jtct.2023.02.012. Epub 2023 Feb 19. Transplant Cell Ther. 2023. PMID: 36809824 Free article.
3,326 results